Deprescription in Advanced Cancer Patients - PubMed (original) (raw)

Review

Deprescription in Advanced Cancer Patients

Ferraz Gonçalves. Pharmacy (Basel). 2018.

Abstract

The use of multiple drugs is often referred to as polypharmacy, although this term has not been precisely defined. Frequently, drugs are used unwisely in multiple combinations increasing the risk of adverse reactions, or for the long-term prevention of diseases in patients with a short life expectancy who, therefore, will not benefit from them. The reflection on this has led to the introduction of the concept of deprescription. There are many reasons for the inappropriate drug prescription and barriers to reduce medications. Tools were developed to help prescribers to limit the number of prescribed drugs that patients are taking. Several studies have shown that deprescription of some drugs is possible and safe and can even have a positive influence on wellbeing, cognitive function, falls, and admission to a hospital. Deprescription should be individualized and carried out, as far as possible, in agreement with patients and their families. A six-step method for deprescription is proposed.

Keywords: deprescription; inappropriate medication; polypharmacy.

PubMed Disclaimer

Conflict of interest statement

The author declares no conflicts of interest.

Similar articles

Cited by

References

    1. Lees J., Chan A. Polypharmacy in elderly patients with cancer: Clinical implications and management. Lancet Oncol. 2011;12:1249–1257. doi: 10.1016/S1470-2045(11)70040-7. - DOI - PubMed
    1. Goldberg R.M., Mabee J., Chan L., Wong S. Drug-Drug and Drug-Disease Interactions in the ED: Analysis of a High-Risk Population. Am. J. Emerg. Med. 1996;14:447–450. doi: 10.1016/S0735-6757(96)90147-3. - DOI - PubMed
    1. Scott I.A., Hilmer S.N., Reeve E., Potter K., Le Couteur D., Rigby D., Gnjidic D., Del Mar C.B., Roughead E.E., Page A., et al. Reducing inappropriate polypharmacy: The process of deprescribing. JAMA Intern. Med. 2015;175:827–834. doi: 10.1001/jamainternmed.2015.0324. - DOI - PubMed
    1. Holmes H.M., Hayley D.C., Alexander G.C., Sachs G.A. Reconsidering medication appropriateness for patients late in life. Arch. Intern. Med. 2006;166:605–609. doi: 10.1001/archinte.166.6.605. - DOI - PubMed
    1. Lee H.R., Yi S.Y., Kim D.Y. Evaluation of prescribing medications for terminal cancer patients near death: Essential or futile. Cancer Res. Treat. 2013;45:220–225. doi: 10.4143/crt.2013.45.3.220. - DOI - PMC - PubMed

Publication types

LinkOut - more resources